Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Molecular mechanisms modulating muscle mass.

David J Glass¹

¹Regeneron Pharmaceuticals, 777 Old Saw Mill River Road, Tarrytown, NY 10591-6707, USA. david.glass@regeneron.com

Trends in Molecular Medicine

|August 21, 2003

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Advantages of Skeletal Muscle Preservation in Settings of Weight Loss.

Aging cell·2026

Same author

Multitissue, multi-time point transcriptomic atlas of aging in mice and rats.

Science advances·2026

Same author

Humans with function-disrupting variants in the myostatin gene (MSTN) have increased skeletal muscle mass and strength, and less adiposity.

Nature communications·2026

Same author

A Cellular and Transcriptomic Atlas of the Aged Mouse Hematopoietic System.

Aging cell·2026

Same author

Optimized murine sample sizes for RNA sequencing studies revealed from large scale comparative analysis.

Nature communications·2025

Same author

PALB2 and 53BP1 govern post-resection homologous recombination DNA repair.

Molecular cell·2025

Same journal

Hyocholic acids: Third bile acids for neonatal health.

Trends in molecular medicine·2026

Same journal

Clonal hematopoiesis in Alzheimer's brain: Protective, pathogenic, and context-dependent?

Trends in molecular medicine·2026

Same journal

Targeting amino acid metabolism in hepatocellular carcinoma.

Trends in molecular medicine·2026

Same journal

Turning perfusion into repair through ferroptosis blockade.

Trends in molecular medicine·2026

Same journal

CaMKK2: A tumor stress-integration node.

Trends in molecular medicine·2026

Same journal

Precision gene editing: From proof-of-concept to curative therapies.

Trends in molecular medicine·2026

See all related articles

Skeletal muscle atrophy, linked to increased proteolysis, involves MAFbx/Atrogin-1 and MuRF1 genes. Stimulating hypertrophy pathways, like with insulin-like growth factor 1 (IGF-1), offers potential therapeutic strategies.

Area of Science:

Biochemistry
Molecular Biology
Physiology

Background:

Skeletal muscle atrophy is a significant issue in conditions like cancer, AIDS, and sepsis.
It is partly driven by enhanced ATP-dependent ubiquitin-mediated proteolysis.
Increased expression of ubiquitin-protein ligases MAFbx/Atrogin-1 and MuRF1 is observed during atrophy.

Purpose of the Study:

To review the molecular mechanisms underlying skeletal muscle atrophy and hypertrophy.
To identify potential therapeutic targets for clinical intervention in muscle wasting diseases.
To discuss the roles of MAFbx/Atrogin-1 and MuRF1 in atrophy and IGF-1/PI3K-Akt in hypertrophy.

Main Methods:

Review of existing literature on muscle atrophy and hypertrophy pathways.

Related Experiment Videos

Analysis of gene expression data related to MAFbx/Atrogin-1 and MuRF1.

Discussion of experimental findings from mouse knockout studies.

Main Results:

MAFbx/Atrogin-1 and MuRF1 are essential for muscle atrophy development.
Mouse knockout models confirm the necessity of MAFbx and MuRF1 for atrophy.
Insulin-like growth factor 1 (IGF-1) promotes hypertrophy via the PI3K-Akt pathway.

Conclusions:

MAFbx/Atrogin-1 and MuRF1 represent key targets for blocking muscle atrophy.
Stimulating hypertrophy pathways, such as the IGF-1/PI3K-Akt axis, is a viable strategy to combat muscle wasting.
Understanding these pathways offers hope for novel clinical interventions.